Tsukuba, Japan

Naoki Ozeki


Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 20(Granted Patents)


Location History:

  • Ibaraki, JP (2005)
  • Tsukuba, JP (2009 - 2010)

Company Filing History:


Years Active: 2005-2010

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Naoki Ozeki: Innovator in Pharmaceutical Chemistry

Introduction

Naoki Ozeki is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Ozeki's latest patents include a compound known as calcium bis[(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl]-2-isopropoxypropionate]. This invention relates to a hydrate and crystal form of the compound, which are useful as pharmaceuticals. The invention addresses the need for a drug substance that minimizes residual solvent content while maintaining favorable workability. Another notable patent involves crystals of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1H)-one, which are suitable for treating conditions such as constipation.

Career Highlights

Throughout his career, Naoki Ozeki has worked with notable companies, including Eisai R&D Management Co., Ltd. and Eisai Company, Limited. His expertise in pharmaceutical development has led to advancements in drug formulation and therapeutic applications.

Collaborations

Ozeki has collaborated with esteemed colleagues such as Hitoshi Harada and Susumu Inoue. These partnerships have contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Naoki Ozeki's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the development of effective therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…